Epidermolysis Bullosa Simplex: Clinical Trials

1 trial for Epidermolysis Bullosa Simplex, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1
Phase 31Completed 1

Follow Epidermolysis Bullosa Simplex: new trials by email Literature Review of Epidermolysis Bullosa Simplex trials Research Report on Epidermolysis Bullosa Simplex

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Injections of Botulinic Toxin in Plantar Lesions of Localized Epidermolysis Bullosa Simplex
Botulinic toxin, Placebo - Epidermolysis Bullosa Simplex
Phase 2 / Phase 3CompletedUniversity Hospital, Toulouse182018-06-142026-09-21

Narrower conditions

Blister (1)

Broader conditions

Congenital Abnormalities (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Epidermolysis Bullosa (1)  ·  Genetic Diseases, Inborn (1)  ·  Pathological Conditions, Anatomical (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Skin Abnormalities (1)  ·  Skin Diseases (1)  ·  Skin Diseases, Genetic (1)  ·  Skin Diseases, Vesiculobullous (1)  ·  Skin and Connective Tissue Diseases (1)

Interventions

Drugs, Investigational (1)  ·  abobotulinumtoxinA (1)

Sponsors

University Hospital, Toulouse (1)

Countries

France (1)

Top investigators

Juliette Mazereeuw-Hautier, MD (1)

NIH funding

2017 (1)